Both software giant Oracle (ORCL) and biotech giant Amgen (AMGN) were in the market Tuesday selling bonds with the proceeds to be used, at least in part, to fund stock buybacks. Oracle launched its second $10 billion offering since June Tuesday and was seeing healthy demand, according to S&P Capital IQ LCD. It was the [...]
No comments:
Post a Comment